Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

EBIT de Calidi Biotherapeutics, Inc..

Dados anuais

2022

2023

TTM

‪‪−32,00 M‬‬

‪‪−24,00 M‬‬

‪‪−16,00 M‬‬

‪‪−8,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

TTM

‪‪−27,57 M‬‬

+‪‪1,42 M‬‬

+‪4,90‬%

2023

‪‪−28,99 M‬‬

‪‪−5,86 M‬‬

‪−25,35‬%

2022

‪‪−23,13 M‬‬

‪‪−21,35 M‬‬

‪‪−1,20 K‬‬%

Dados trimestrais

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−10,00 M‬‬

‪‪−7,50 M‬‬

‪‪−5,00 M‬‬

‪‪−2,50 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪−5,23 M‬‬

+‪‪546,00 K‬‬

+‪9,46‬%

Q2 '24

‪‪−5,77 M‬‬

+‪‪980,00 K‬‬

+‪14,51‬%

Q1 '24

‪‪−6,75 M‬‬

+‪‪3,07 M‬‬

+‪31,24‬%

Q4 '23

‪‪−9,82 M‬‬

‪‪−2,60 M‬‬

‪−35,99‬%

Q3 '23

‪‪−7,22 M‬‬

‪‪−5,73 M‬‬

‪−382,77‬%

Q2 '23

‪‪−1,50 M‬‬

+‪‪533,47 K‬‬

+‪26,29‬%

Q1 '23

‪‪−2,03 M‬‬

+‪‪685,55 K‬‬

+‪25,25‬%

Q4 '22

‪‪−2,71 M‬‬

‪‪−1,65 M‬‬

‪−155,08‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21